المؤلفون: Chen EC; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Gibson W; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Temoczko P; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Connell NT; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Handin R; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Parnes AD; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

المصدر: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Jan; Vol. 29 (1), pp. 84-89. Date of Electronic Publication: 2022 Sep 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2516 (Electronic) Linking ISSN: 13518216 NLM ISO Abbreviation: Haemophilia Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/therapeutic use , Antibodies, Bispecific*/pharmacology , Hemophilia A*/drug therapy , Hemostatics*, Humans ; Factor VIII/antagonists & inhibitors ; Prospective Studies ; Retrospective Studies

SCR Disease Name: Factor 8 deficiency, acquired

المؤلفون: Ostrominski JW, Vaidya A, Parnes AD, Tyan K, Tsai FD

المصدر: The New England journal of medicine [N Engl J Med] 2022 Oct 27; Vol. 387 (17), pp. e41.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Endothelium, Vascular*, Humans ; Stress, Mechanical

المؤلفون: Shafqat S; Medical College, Aga Khan University, Karachi, Pakistan., Tariq E; Medical College, Aga Khan University, Karachi, Pakistan., Parnes AD; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA., Dasouki MJ; Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Ahmed SO; Department of Adult Hematology and Stem Cell Transplantation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Hashmi SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: Hashmi.shahrukh@mayo.edu.

المصدر: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2021 Dec; Vol. 14 (4), pp. 290-301. Date of Electronic Publication: 2021 Mar 07.

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre Country of Publication: Saudi Arabia NLM ID: 101468532 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-0646 (Electronic) Linking ISSN: 25890646 NLM ISO Abbreviation: Hematol Oncol Stem Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Fanconi Anemia*/genetics , Fanconi Anemia*/therapy, Adolescent ; Child ; Child, Preschool ; Genetic Therapy ; Humans

المؤلفون: Stern RM; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Michaelson MD; Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Mayer EL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Parnes AD; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Fogerty AE; Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., LaCasce AS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Nipp RD; Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

المصدر: JCO oncology practice [JCO Oncol Pract] 2021 Sep; Vol. 17 (9), pp. 541-545. Date of Electronic Publication: 2021 Feb 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Hematology* , Neoplasms*, Fellowships and Scholarships ; Humans ; Pandemics ; SARS-CoV-2 ; United States

المؤلفون: Al-Samkari H; Div of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA., Parnes AD; Hematology Division, Brigham and Womens Hospital, Boston, USA., Goodarzi K; Div of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA., Weitzman JI; Division of Hematology Oncology, Newton-Wellesley Hospital, Newton, USA., Connors JM; Hematology Division, Brigham and Women Hospital, Harvard Medical School, Boston, USA., Kuter DJ; Div of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.

المصدر: Haematologica [Haematologica] 2021 Apr 01; Vol. 106 (4), pp. 1148-1157. Date of Electronic Publication: 2021 Apr 01.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Hematologic Neoplasms*/drug therapy , Neoplasms*/complications , Neoplasms*/drug therapy , Thrombocytopenia*/chemically induced , Thrombocytopenia*/drug therapy, Humans ; Receptors, Fc/therapeutic use ; Recombinant Fusion Proteins/therapeutic use ; Retrospective Studies ; Thrombopoietin/therapeutic use

المؤلفون: Chakraborty R; Hospitalist Services, Essentia Health-St. Joseph's Medical Center,Brainerd,Minnesota., El-Jawahri AR; Division of Hematology/Oncology,Massachusetts General Hospital,Boston,Massachusetts., Litzow MR; Division of Hematology,Mayo Clinic,Rochester,Minnesota., Syrjala KL; Department of Psychiatry and Behavioral Sciences,Fred Hutchinson Cancer Research Center,Seattle,Washington., Parnes AD; Department of Medicine,Brigham and Women's Hospital,Harvard Medical School,Boston,Massachusetts., Hashmi SK; Division of Hematology,Mayo Clinic,Rochester,Minnesota.

المصدر: Palliative & supportive care [Palliat Support Care] 2017 Oct; Vol. 15 (5), pp. 609-622.

نوع المنشور: Journal Article; Review; Systematic Review

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 101232529 Publication Model: Print Cited Medium: Internet ISSN: 1478-9523 (Electronic) Linking ISSN: 14789515 NLM ISO Abbreviation: Palliat Support Care Subsets: MEDLINE

مواضيع طبية MeSH: Attitude to Health* , Religion*, Health Personnel/*psychology , Terminal Care/*psychology, Buddhism/psychology ; Christianity/psychology ; Hinduism/psychology ; Humans ; Islam/psychology ; Judaism/psychology ; Suicide, Assisted/psychology ; Terminal Care/trends

المؤلفون: Vaidya AP; Department of Oncology, Massachusetts General Hospital, Cox 6, 100 Blossom St., Boston, MA, 02114, USA., Parnes AD, Seiden MV

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2005 Mar; Vol. 6 (2), pp. 103-14.

نوع المنشور: Comparative Study; Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print Cited Medium: Print ISSN: 1527-2729 (Print) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors/*antagonists & inhibitors , ErbB Receptors/*therapeutic use , Genital Neoplasms, Female/*drug therapy , Genital Neoplasms, Female/*pathology, Biological Availability ; Clinical Trials, Phase II as Topic ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Endometrial Neoplasms/drug therapy ; Endometrial Neoplasms/mortality ; Endometrial Neoplasms/pathology ; Female ; Genital Neoplasms, Female/mortality ; Humans ; Maximum Tolerated Dose ; Neoplasm Staging ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Prognosis ; Risk Assessment ; Survival Analysis ; Treatment Outcome ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/pathology